Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tuloxxin 100 mg/ml V/DCP/18/0079 KRKA, d.d., Novo mesto, Slovēnija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 28-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 171221LI (10-Apr-2024)
Labelling text: [PDF] 171221M (10-Apr-2024)
Summary of product characteristics: [DOCX] 171221ZA (10-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0079-01 1 Stikla flakons, 50 ml -
V/DCP/18/0079-02 1 Stikla flakons, 100 ml -
V/DCP/18/0079-03 1 Stikla flakons, 250 ml -
Tolfelab 40 mg/ml V/DCP/22/0045 Labiana Life Sciences S.A., Spānija QM01AG02 cattle; pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tolfenamic acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 30-Nov-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Nov-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0045-01 1 Stikla flakons, 20 ml -
V/DCP/22/0045-02 1 Stikla flakons, 50 ml -
V/DCP/22/0045-03 1 Stikla flakons, 100 ml -
V/DCP/22/0045-04 1 Stikla flakons, 250 ml -
Cepritect 250 mg V/DCP/17/0049 Norbrook Laboratories (Ireland) Limited, Īrija QJ51DB90 dry cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalonium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0049-01 24 Injektors, 3 g -
V/DCP/17/0049-02 60 Injektors, 3 g -
V/DCP/17/0049-03 120 Injektors, 3 g -
Milprazon 16 mg/40 mg - V/DCP/14/0073 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 cats weighing at least 2 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0073-01 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/14/0073-02 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/14/0073-03 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Bupredine Multidose vet 0.3 mg/ml V/DCP/15/0048 Le Vet Beheer B.V., Nīderlande QN02AE01 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Buprenorphine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 20-Dec-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 20122021LI (23-Dec-2021)
Labelling text: [DOCX] 20122021M (23-Dec-2021)
Summary of product characteristics: [DOCX] 20122021ZA (23-Dec-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0048-01 0,3 mg/ml 1 Stikla flakons, 5 ml -
V/DCP/15/0048-02 0,3 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/15/0048-03 0,3 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/15/0048-04 0,3 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/15/0048-05 0,3 mg/ml 1 Stikla flakons, 100 ml -
Ultrapen LA 300 mg/ml V/NRP/98/0939 Norbrook Laboratories (Ireland) Limited, Īrija QJ01CE09 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Procaine benzylpenicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 09-Feb-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 15052024_LI (14-May-2024)
Labelling text: [DOCX] 15052024_M (14-May-2024)
Summary of product characteristics: [DOCX] 15052024_ZA (14-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0939-01 300 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/98/0939-02 300 mg/ml 1 Stikla flakons, 100 ml -
Be-Complex - V/NRP/94/0280 Bela-pharm GmbH&Co.KG, Vācija QA11EX cattle; pigs; horses; dogs; cats; minks; foxes Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Thiamine hydrochloride, Riboflavine sodium phosphate, Pyridoxine hydrochloride, Nicotinamide, Calcium pantothenate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/94/0280-01 1 Stikla flakons, 50 ml -
V/NRP/94/0280-02 6 Stikla flakons, 50 ml -
V/NRP/94/0280-03 12 Stikla flakons, 50 ml -
V/NRP/94/0280-08 1 Stikla flakons, 100 ml -
V/NRP/94/0280-09 6 Stikla flakons, 100 ml -
V/NRP/94/0280-10 12 Stikla flakons, 100 ml -
V/NRP/94/0280-15 1 Stikla flakons, 250 ml -
V/NRP/94/0280-16 6 Stikla (tumša) flakons, 250 ml -
V/NRP/94/0280-17 12 Stikla flakons, 250 ml -
Nobilis Reo+IB+G+ND - V/NRP/95/0179 Intervet International B.V., Nīderlande QI01AA16 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Newcastle disease virus, strain Clone 30,Inactivated reovirus strain 1733 and 2408,Inactivated avian infectious bronchitis virus, strain M41 ,Inactivated infectious bursal disease virus, strain D78
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0179-01 1 Stikla flakons, 1000 deva -
V/NRP/95/0179-02 1 PET pudele, 1000 deva -
Benestermycin - V/NRP/96/0294 Boehringer Ingelheim Vetmedica GmbH, Vācija QJ51RC25 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Penethamate hydroiodide, Benethamine penicillin, Framycetin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija;Lohmann Pharma Herstellung GmbH, Vācija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0294-01 20 Injektors, 1 deva -
Cobactan LC 75 mg V/NRP/01/1288 Intervet International BV, Nīderlande QJ51DE90 cattle (lactating cows) Vairāk

Medicinal product information

Pharmaceutical form: intramammary ointment
International name (active substance): Cefquinome (as cefquinome sulfate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Hoechst Roussel Vet, Francija;Intervet International BV, Nīderlande;INTERVET INTERNATIONAL GMBH, Vācija
Date of authorisation/renewal: 03-Aug-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1288-01 75 mg/deva 3 Injektors, 1 deva -
V/NRP/01/1288-02 75 mg/deva 15 Injektors, 1 deva -
V/NRP/01/1288-03 75 mg/deva 20 Injektors, 1 deva -
V/NRP/01/1288-04 75 mg/deva 24 Injektors, 1 deva -
Bovilis IBR marker live - V/NRP/02/1525 Intervet International B.V., Nīderlande QI02AD01 cattle Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Inactivated antigen of BHV-1 (gE) strain GK/D
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Oct-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1525-05 1 Stikla flakons, 5 deva -
V/NRP/02/1525-06 10 Stikla flakons, 10 deva -
V/NRP/02/1525-07 10 Stikla flakons, 5 deva -
V/NRP/02/1525-08 1 Stikla flakons, 10 deva -
V/NRP/02/1525-09 1 Stikla flakons, 25 deva -
V/NRP/02/1525-10 10 Stikla flakons, 25 deva -
V/NRP/02/1525-11 1 Stikla flakons (šķīdinātājs stikla flakonā), 50 deva -
V/NRP/02/1525-12 10 Stikla flakons (šķīdinātājs stikla flakonā), 50 deva -
V/NRP/02/1525-13 1 Stikla flakons, 100 deva -
V/NRP/02/1525-14 10 Stikla flakons, 100 deva -
V/NRP/02/1525-15 1 Stikla flakons (šķīdinātājs PET flakonā), 50 deva -
V/NRP/02/1525-16 10 Stikla flakons (šķīdinātājs PET flakonā), 50 deva -
Floron oral solution 100 mg/ml - V/NRP/01/1416 KRKA, d.d., Novo mesto, Slovēnija QJ01BA90 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Florfenicol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 19-Jan-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1416-01 100 mg/ml 1 Pudelīte, 100 ml -
V/NRP/01/1416-02 100 mg/ml 1 Flakons, 1000 ml -
Nobilis Reo inac - V/NRP/03/1558 Intervet International B.V., Nīderlande QI01AA04 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Reoviruss
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1558-01 1 Stikla flakons, 1000 deva -
V/NRP/03/1558-03 1 PET flakons, 1000 deva -
Bimectin 10 mg/ml V/NRP/07/1703 Bimeda Animal Health Limited, Īrija QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bimeda Animal Health Limited, Īrija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1703-01 10 mg/ml 1 Polietilēna pudele, 50 ml -
V/NRP/07/1703-02 10 mg/ml 1 Polietilēna pudele, 250 ml -
V/NRP/07/1703-03 10 mg/ml 1 Polietilēna pudele, 500 ml -
Marbocyl P 80mg - V/NRP/08/1577 Vetoquinol S.A., Francija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 090710LI (19-Jul-2010)
Labelling text: [DOC] 090710_M (19-Jul-2010)
Summary of product characteristics: [PDF] 090710ZA (19-Jul-2010)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1577-01 80 mg 1 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-02 80 mg 2 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-03 80 mg 3 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-04 80 mg 4 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-05 80 mg 5 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-06 80 mg 8 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-07 80 mg 12 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-08 80 mg 16 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-09 80 mg 20 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-10 80 mg 40 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-11 80 mg 80 Alumīnija blisteris, 6 tablete -
Porcilis Ery - V/NRP/96/0377 Intervet International B.V., Nīderlande QI09AB03 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Erysipelothrix rhusiopathiae, serotype 2, strain M2
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0377-01 1 Pudelīte, 10 deva -
V/NRP/96/0377-02 1 Pudelīte, 25 deva -
V/NRP/96/0377-03 1 Pudelīte, 50 deva -
V/NRP/96/0377-04 1 Pudelīte, 125 deva -
Nafpenzal DC - V/NRP/93/0034 Intervet International B.V., Nīderlande QJ51RC23 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Procaine benzylpenicillin, Nafcillin, Dihydrostreptomycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0034-01 4 Injektors, 1 deva -
V/NRP/93/0034-02 20 Injektors, 1 deva -
BioEquin FT - V/NRP/20/0021 Bioveta, ,a.s., Čehija QI05AL01 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated equine influenza virus, strain A/Equi 2/Brno 08 (American type) H3N8, Inactivated equine influenza virus, strain A/Equi 2/ Morava 95 (European type) H3N8, Tetanus toxoid
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 23102020LI (23-Oct-2020)
Labelling text: [DOCX] 23102020M (23-Oct-2020)
Summary of product characteristics: [DOCX] 23102020ZA (23-Oct-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/20/0021-01 2 Stikla flakons, 1 deva -
V/NRP/20/0021-02 5 Stikla flakons, 1 deva -
V/NRP/20/0021-03 10 Stikla flakons, 1 deva -
V/NRP/20/0021-04 1 Stikla flakons, 5 deva -
V/NRP/20/0021-05 10 Stikla flakons, 5 deva -
MELCAM 1.5 mg/ml 1.5 mg/ml V/NRP/22/0009 Bioveta, a.s., Čehija QM01AC06 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 260722LI (26-Jul-2022)
Labelling text: [DOCX] 260722M (26-Jul-2022)
Summary of product characteristics: [DOCX] 260272ZA (26-Jul-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/22/0009-01 1 Polietilēna pudele, 10 ml -
V/NRP/22/0009-02 1 Polietilēna pudele, 30 ml -
V/NRP/22/0009-03 1 Polietilēna pudele, 100 ml -
Intramar LC - V/NRP/20/0064 Bioveta, a.s., Čehija QJ51RV01 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26012021LI (26-Jan-2021)
Labelling text: [DOCX] 26012021M (26-Jan-2021)
Summary of product characteristics: [DOCX] 26012021ZA (26-Jan-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/20/0064-01 24 Injektors, 4 g -

3081 record